FORWARD PHARMA A/S: Financial statements 2022
CVR: 28865880
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -11,631,794 and a net result of DKK -31,482,847 compared with DKK -12,271,137 the year before. Equity in the 2022 report amounted to DKK 430,396,730. The solvency ratio was 81.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -11,631,794
- Profit/Loss
- DKK -31,482,847
- Equity
- DKK 430,396,730
- Total Assets
- DKK 529,878,486
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -11.6 mio. | -31.5 mio. | 430.4 mio. | 2 |
| 2021 | - | -10.8 mio. | -12.3 mio. | 461.9 mio. | 2 |
| 2020 | - | -7.8 mio. | -42.2 mio. | 474.1 mio. | 2 |
| 2019 | - | -6 mio. | -28.5 mio. | 515.9 mio. | 3 |
| 2018 | 0 | -7.6 mio. | -54.3 mio. | 534.6 mio. | 3 |
Official annual report
Keep an eye on FORWARD PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
FORWARD PHARMA A/S has published its annual report for 2021. Gross profit came to DKK -10,812,930, and the net result was DKK -12,271,137.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.